| View |
|
BR-1133
|
Pneumococcal Conjugate Vaccine, 13-Valent
(adsorbed) [See formulation on reverse side]
|
Prevenar 13
|
0.5 mL
|
Suspension For Injection (IM)
|
-
|
Pfizer Ireland Pharmaceuticals
|
Ireland
|
-
|
10 September 2021
|
21 January 2026
|
| View |
|
BR-1135
|
Chorionic Gonadotrophin
|
Chorapur
|
5000 IU
|
Powder for Injection (IM)
|
-
|
Ferring GmbH
|
Germany
|
-
|
08 March 2021
|
09 February 2026
|
| View |
|
BR-1136
|
Bevacizumab
|
Mvasi
|
100 mg/4 mL (25 mg/mL)
|
Concentrate For Solution For Infusion (IV)
|
-
|
Amgen Manufacturing Limited
|
USA
|
Initial
|
28 January 2021
|
28 January 2026
|
| View |
|
BR-1138
|
Pembrolizumab
|
Keytruda
|
100mg/4mL (25mg/mL
|
Solution For Injection (IV Infusion)
|
Antineoplastic
|
MSD International GmbH T/A MSD Ireland (Carlow)
|
Ireland
|
Initial
|
06 July 2021
|
17 February 2026
|
| View |
|
BR-1141
|
Rituximab
|
Mabthera
|
10 mg/ mL
|
Concentrate For Solution For Infusion (IV)
|
-
|
Roche Diagnostic GmbH
|
Germany
|
-
|
08 March 2021
|
24 November 2025
|
| View |
|
BR-1147
|
Pneumococcal Vaccine, Polyvalent
|
Pneumovax 23
|
25mcg/0.5mL
(serotypes: 1,2,3,4,5,6B,7F,8,9N,9V,
10A,11A,12F,14,15B,17F,18C,19F,19A,20,22F,23F,33F
dissolved in isotonic saline soln containing 0.25%
phenol as preservative)
|
Solution For Injection (S.C./I.M.)
|
-
|
Merck Sharp & Dohme Corp.
|
USA
|
-
|
19 April 2021
|
11 April 2026
|
| View |
|
BR-1152
|
Siltuximab
|
Sylvant
|
100 mg
|
Powder For Concentrate For Solution For Infusion
|
-
|
Cilag AG
|
Switzerland
|
Initial
|
19 October 2021
|
04 August 2026
|
| View |
|
BR-1153
|
Siltuximab
|
Sylvant
|
400 mg
|
Powder For Concentrate For Solution For Infusion
|
-
|
Cilag AG
|
Switzerland
|
Initial
|
16 November 2021
|
04 August 2026
|
| View |
|
BR-1154
|
Basagine
|
Insulin Glargine
|
100 Units/mL
|
Solution For Injection (SC)
|
-
|
Getz Pharma Pvt. Ltd.
|
Pakistan
|
-
|
27 April 2021
|
03 June 2026
|
| View |
|
BR-1155
|
Human Normal Immunoglobulin
|
Octagam 10%
|
100mg/mL (10% w/v)
|
Solution for IV Infusion
|
-
|
Octapharma Pharmazeutika Produktionsges.m.b.H
|
Austria
|
-
|
25 March 2022
|
07 June 2026
|
| View |
|
BR-1156
|
Human Normal Immunoglobulin
|
Octagam 5%
|
50mg/mL (5% w/v)
|
Solution for IV Infusion
|
-
|
Octapharma Pharmazeutika Produktionsges.m.b.H
|
Austria
|
-
|
25 March 2022
|
07 June 2026
|
| View |
|
BR-1157
|
Human Albumin
|
Albunorm 25%
|
250 g/L (25% w/v)
|
Solution for IV Infusion
|
-
|
Octapharma
|
France
|
-
|
20 January 2022
|
06 June 2026
|
| View |
|
BR-1161
|
Insulin Human (rDNA)
|
Scilin M30
|
30% Soluble Insulin + 70% Isophane Insulin 100 IU/mL
|
Suspension For Injection (SC)
|
-
|
Bioton S.A.
|
Poland
|
Regular Renewal
|
26 February 2021
|
04 October 2025
|
| View |
|
BR-1162
|
Insulin Human (rDNA)
|
Scilin N
|
Isophane 100 IU/mL
|
Suspension For Injection (Sc)
|
-
|
Bioton S.A.
|
Poland
|
Renewal (Variation) [Reconstruction]
|
28 July 2023
|
28 October 2025
|
| View |
|
BR-1163
|
Insulin Human (rDNA)
|
Scilin N
|
Isophane 100 IU/mL
|
Suspension For Injection (SC)
|
-
|
Bioton S.A.
|
Poland
|
Regular Renewal
|
26 February 2021
|
04 October 2025
|
| View |
|
BR-1165
|
Human Albumin
|
Albunorm 20%
|
200 g/L (20% w/v)
|
Solution for IV Infusion
|
Blood substitutes and plasma protein fractions
|
Octapharma Produktionsgesellschaft Deutschland GmbH
|
Germany
|
Automatic Renewal
|
26 October 2021
|
26 July 2026
|
| View |
|
BR-1168
|
Human Papillomavirus 9-Valent Vaccine (Recombinant, Adsorbed)
|
Gardasil 9
|
Formulation: Each dose (0.5 mL) contains: Human Papillomavirus Type 6 L1 protein-30mcg Human Papillomavirus Type 11 L1 protein-40mcg Human Papillomavirus Type 16 Ll protein-60mcg Human Papillomavirus Type 18 Li protein-40mcg Human Papillomavirus Type 31 Ll protein-20 mcg Human Papillomavirus Type 33 L1 protein-20mcg Human Papillomavirus Type 45 Ll protein-20mcg Human Papillomavirus Type 52 L1 protein-20mcg Human Papillomavirus Type 58 LI protein-20mcg
Adsorbed on amorphous aluminum hydroxide sulphate adjuvant -500 mcg Al
|
Suspension for Injection (IM)
|
-
|
Merck Sharp & Dohme Corp.
|
United States of America
|
Initial
|
30 March 2022
|
19 August 2026
|
| View |
|
BR-1173
|
Human Albumin
|
Albunorm 5%
|
50 g/L
|
Solution for Intravenous Infusion
|
Blood Substitute and Plasma Protein Fractions
|
Octapharma Produktiongesellschaft Deutschland mbH
|
Germany
|
Automatic Renewal
|
13 August 2021
|
05 September 2026
|
| View |
|
BR-1174
|
Human Albumin
|
Albunorm 5%
|
50 g/L
|
Solution for Intravenous Infusion
|
-
|
Octapharma AB
|
Sweden
|
Automatic Renewal
|
13 August 2021
|
05 September 2026
|
| View |
|
BR-1175
|
Filgrastim
|
Topneutor
|
150 mcg/mL
|
Solution for Injection (IV/SC)
|
Immunostimulant
|
Xiamen Amoytop Biotech Co., Ltd.
|
China
|
Automatic Renewal
|
24 September 2021
|
24 August 2026
|